Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $192.62 million as of December 20, 2024. Its market cap has increased by 168.65% in one year.

• Market Cap: 192.62M
• Enterprise Value: -70.95M
• 1-Year Change: 168.65%
• Ranking: #3657
• Category: Micro-Cap
• Stock Price: $2.85

Market Cap Chart

Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $192.62M, an increase of 286.80%. That is a compound annual growth rate of 7.33%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	192.60M	70.74%
Dec 29, 2023	112.80M	221.37%
Dec 30, 2022	35.10M	-36.18%
Dec 31, 2021	55.00M	39.95%
Dec 31, 2020	39.30M	-6.65%
Dec 31, 2019	42.10M	108.42%
Dec 31, 2018	20.20M	-8.18%
Dec 29, 2017	22.00M	-31.03%
Dec 30, 2016	31.90M	-38.18%
Dec 31, 2015	51.60M	-35.58%
Dec 31, 2014	80.10M	317.19%
Dec 31, 2013	19.20M	-28.89%
Dec 31, 2012	27.00M	41.36%
Dec 30, 2011	19.10M	-28.20%
Dec 31, 2010	26.60M	30.39%
Dec 31, 2009	20.40M	343.48%
Dec 31, 2008	4.60M	-90.09%
Dec 31, 2007	46.40M	-40.28%
Dec 29, 2006	77.70M	9.75%
Dec 30, 2005	70.80M	42.17%

View and export this data all the way back to 2005. Sign Up Today.

Related Stocks

Company	Market Cap
Inogen	199.36M
Molecular Partners AG	199.32M
Verastem	198.72M
Inhibrx Biosciences	197.96M
MacroGenics	197.08M
Inventiva	196.18M
Akso Health Group	193.95M
XBiotech	192.96M